Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback